Derakhshan Behrad reported grant involving 100,000 derivative units of Edgewise Therapeutics, Inc. at $0.00 for $0 on Aug 12, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Chief Business Officer
Chief Business Officer
Filed Aug 17, 2026

Facts from the filing

Form 4/A · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
100,000Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
100,000Direct
Trade date
Aug 12, 2026Grant
Filed
Aug 17, 2026, 6:39 PM ET5-day reporting delay
Accession
0001853109-26-000002Code A · Transaction 1294
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

This amendment is separate from the original filing. It may contain only changed rows. Read both SEC reports.

Filing warnings

Notes recorded with this filing
1 warning
amended filingThis transaction comes from an amended Form 4 filing.

EWTX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
EWTX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −11%1w ago −13%1d ago −13%
Returns since7d +1.5%30d +3.2%90d +4.3%180d1y

Footnotes in full

F1: 1/48th of the shares subject to the option vest each month beginning on September 12, 2026, subject to the Reporting Person continuing as a service provider through each vest date.